Sentences with phrase «cell and gene meeting»

SAN DIEGO, October 4, 2017 — ViaCyte, Inc., a privately - held regenerative medicine company, today announced upcoming company presentations at the Cell and Gene Meeting on the Mesa and the BIO Investor Forum.

Event: Cell and Gene Meeting on the Mesa & Partnering Forum Speaker: Paul Laikind, Ph.D., President and CEO of ViaCyte Date / Time: October 5, 9:45 am PT Location: La Jolla, California

Not exact matches

Within 24 hours, the team found that H. pylori was causing the organoid cells to divide twice as fast as normal, and activating a particular gene, c - Met, that can cause tumours.

To see if the remaining 382 genes meet the minimum requirement for life, Venter's team will have to build a genome with them and drop it into a cell.

It showed effectiveness against liver cancer in a phase II clinical trial and will move into a phase III trial later this year, David Kirn, an oncologist and the company's president and chief executive officer, said at a recent meeting of the American Society for Gene & Cell Therapy in Washington, D.C..

At the meeting, team member Koffi Konan, a plant molecular biologist, showed how the plants were made by inserting shortened or backward versions of each of the genes — Ara h1, Ara h2, and Ara h3 — into cultured cells from peanut plants.

McKay and Tsai conclude that nucleostemin is involved in regulating the proliferation of both stem cells and at least some types of cancer cells, they reported at a meeting here on 20 November and in the December issue of Genes & Development.

Topics for the scientific sessions are: Single cell genomics and gene expression Genetic interactions RNAi and somatic cell genetics Protein - DNA interactions Cancer The meeting also highlights existing opportunities for academic and industrial researchers to access automated cell - based and biochemical technologies based at the Karolinska High Throughput Center; home to one of the most sophisticated, state - of - the - art, ultra-high performance liquid handling and analysis platforms in Europe.

We are focusing on a few key molecular pathways including; 1) Polycomb - mediated epigenetic gene silencing in the tumor initiation, maintenance, and invasion, 2) c - Met (receptor tyrosine kinase) signal transduction pathways in stemness and migration of these tumor cells, 3) Novel mitogenic signaling pathways that are specific to GSCs, and 4) Identification of radio - and chemo - sensitizing pathway to maximize therapeutic efficacy.

Data from this trial was previously presented at World Advanced Therapies and Regenerative Medicine (May 17 - 19,2017; London, UK) and the 20th Annual Meeting American Society of Gene and Cell Therapy (ASGCT, May 10 - 13, 2017; DC, USA).

Scholar - in - Training Awards in the amount of $ 1,000 for her submitted abstract entitled, «Activator protein 2 alpha (AP2α)- targeted methylation and silencing of relevant genes in head and neck squamous cell carcinoma (HNSCC) pathogenesis» to be presented at platform session at the 100th Annual Meeting of the American Association for Cancer Research, Denver, CO..

American Society of Gene and Cell Therapy Annual Meeting Speaker: Olivia Kelly, Ph.D., Senior Director, Cell Biology Presentation: Developing a Cell Therapy Combination Product for Diabetes Date / Time: May 16, 8:30 AM EDT Location: Hilton Chicago, Chicago

Drs. Jean Bennett, Luk Vandenberghe, Luca Biasco, and Francesca Pasinelli will be recognized for their tremendous contributions to gene and cell therapy at ASGCT's 21st Annual Meeting.

ASGCT's annual meeting is the essential scientific conference for professionals in gene and cell therapy.

Similarly, microarray analyses comparing global gene expression in cells that overexpress wild - type STAT3 or phosphorylation - deficient mutant indicate that a subset of genes are regulated by unphosphorylated STAT3, including well - known oncogenes such as MRAS and MET (Yang et al., 2005).

Focused on meeting this urgent unmet medical need, ALS TDI executes a robust target discovery program, while simultaneously operating the world's largest efforts to preclinically validate potential therapeutics; including a pipeline of dozens of small molecules, protein biologics, gene therapies and cell - based constructs.

Then we meet Lena (Natalie Portman), a professor of biology at Johns Hopkins whose research specialty is the single cell: its genes and its lifespan.